about
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart FailureAdvances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm SocietyAutonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study.Utility of implantable loop recorder (Reveal Plus) in the diagnosis of unexplained syncope.Holter Monitoring and Loop Recorders: From Research to Clinical Practice.An update on: cardiovascular and respiratory changes during sleep in normal and hypertensive subjects.Sudden cardiac death: role of heart rate variability to identify patients at risk.Pharmacological treatment of atrial fibrillation: mechanisms of action and efficacy of class III drugs.Clinical implications of present physiological understanding of HRV components.'Engage me in taking care of my heart': a grounded theory study on patient-cardiologist relationship in the hospital management of heart failure.Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial.Renin-angiotensin system block and atrial fibrillation.Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications.Anti-arrhythmic properties of N-3 poly-unsaturated fatty acids (n-3 PUFA).Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus.Dronedarone for atrial fibrillation therapy.The neural regulation of circulation explored in the frequency domain.Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery.Italian Chapter of the International Society of Cardiovascular Ultrasound expert consensus document on coronary computed tomography angiography: overview and new insights.Cardiovascular Profile of Propranolol after Multiple Dosing in Infantile Hemangioma.Prognostic value of signal-averaged electrocardiogram in Chagas disease.Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease.Power-law behavior of heart rate variability in Chagas' disease.Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.Origin of heart rate variability and turbulence: an appraisal of autonomic modulation of cardiovascular function.Spatial repolarization heterogeneity and survival in Chagas disease.Heart rate variability regression and risk of sudden unexpected death in epilepsy.The STRATEGY Study (Stress Cardiac Magnetic Resonance Versus Computed Tomography Coronary Angiography for the Management of Symptomatic Revascularized Patients): Resources and Outcomes Impact.Physiology and clinical implications of variability of cardiovascular parameters with focus on heart rate and blood pressure.Power spectral analysis of cardiovascular variability in patients at risk for sudden cardiac death.Heart rate variability and its sympatho-vagal modulation.Enhanced parasympathetic activity in Chagas disease still stands in need of proof.Heart rate variability and cardiac failure.Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.Prevention of contrast-induced nephropathy: a single center randomized study.T-wave amplitude variability and the risk of death in Chagas disease.Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion.ICDs in Chagas heart disease: the standard treatment for secondary prevention of sudden death.Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.
P50
Q26753845-4947F688-0AF2-4EF6-8B45-CAB3718B1564Q26801302-CA8AE3C4-BB5D-49C1-BED6-7A0FFBD23A3AQ30438683-4C3ACDCD-C477-447C-9492-5B78B2D5033CQ33152296-1DF652E9-BB96-47BA-8038-A7D312D3C59BQ33167676-E52AADF7-17EE-41CB-B76D-CFA51B894307Q33869939-CEDC32E7-9CAC-4A01-A04B-DDA968741C7EQ34239949-B673E2EC-ABBD-47F1-A5BB-C5D60FE5F164Q34540221-B26F1DAC-4DFB-4A11-88A5-4892B666787AQ34736079-14FD34F3-3B3B-44D1-9312-51A31D1FFF5AQ35204032-883248CA-CF2F-4673-9F71-AB46A847E93AQ36141379-0A6A1999-7454-49CB-9632-70E968E661C7Q36172978-806D5030-0C9F-46B0-B810-B35D1C640E9DQ36624238-7248B3F6-2177-4FBD-B00F-8F73237C2CE6Q36907305-E5B24B25-20FE-4A41-82C8-1B43990F4985Q36960923-95B36EAE-5C92-47BB-8951-2998B9177A13Q37304888-0371B8BB-7241-4265-9053-9D8DC9076D62Q37895677-20EFBF03-4A83-4F4A-9D9F-8BC3099C4C5CQ37962370-E7FEF300-BE96-4D9A-9D96-E78E36C36162Q38377588-AFBF35DA-689B-44C6-B393-6538C55AAAF5Q38859262-44067CFF-BF18-46AC-BB7D-C99B3E64B224Q39275660-1F9025EE-BC7A-4618-8FFA-082BEF89B771Q39396004-11C85C28-257F-4787-97FD-CA50A18315C3Q39396010-CB6898B6-A948-4965-8C6E-21B86282B726Q39396037-209A373B-AED7-4A1E-A8CA-674B408E6A6CQ39403108-C6159CAE-9C70-4607-A829-4894760DB66BQ39686751-BED0AB6F-45E3-4A12-BB4D-1B91316B8D48Q40203308-A0DC0EF1-9EC8-48F9-809A-9BD31D9A7061Q40369553-83E2AA0D-4487-4082-BD6E-D51AC6B66B0CQ40453592-9EC29B0A-06BF-4440-826A-420AF78755E4Q40744385-F69E4D18-4E56-4B36-B426-138CA3C9F03BQ40757695-F45C1D06-0CC4-400C-B96C-F4B1F0D5235EQ41104840-B2FEC7E6-DFF3-4D80-A203-587CFCFF3D4AQ42961917-75B066CD-3F15-4B9D-B680-52F8E981B894Q43037067-A70C6EEE-3133-4FF5-9D46-09AF989A9007Q43077325-4DF1476F-96B0-45C0-9443-0A927C6D65CDQ43175944-3EDEDB0C-7A03-424E-AB5C-FF4B6935F494Q43462885-8EF94AA2-AA7E-41F4-9BF9-1B92143E1F42Q43518208-818E00F1-414D-49F4-B720-F6A981EF9B0FQ43968820-C0AFFA9F-D369-4E67-B149-F4D348F133E4Q44095273-8D191D1A-008C-4C86-8CA9-79500E529722
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2424-2509
@en
name
Federico Lombardi
@ast
Federico Lombardi
@en
Federico Lombardi
@es
Federico Lombardi
@nl
type
label
Federico Lombardi
@ast
Federico Lombardi
@en
Federico Lombardi
@es
Federico Lombardi
@nl
prefLabel
Federico Lombardi
@ast
Federico Lombardi
@en
Federico Lombardi
@es
Federico Lombardi
@nl
P106
P1153
7202555768
P21
P31
P496
0000-0003-2424-2509